Laurent Arnaud

Research interests

Publications

• EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

  Annals of the Rheumatic Diseases · 2023 · https://doi.org/10.1136/ard-2023-224762

• Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases

  The Lancet Rheumatology · 2021 · https://doi.org/10.1016/s2665-9913(21)00039-4

• 2021 DORIS definition of remission in SLE: final recommendations from an international task force

  Lupus Science & Medicine · 2021 · https://doi.org/10.1136/lupus-2021-000538

• COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

  The Lancet Rheumatology · 2021 · https://doi.org/10.1016/s2665-9913(21)00059-x

• Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

  Autoimmunity Reviews · 2020 · https://doi.org/10.1016/j.autrev.2020.102531

• A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

  Annals of the Rheumatic Diseases · 2016 · https://doi.org/10.1136/annrheumdis-2016-209519

• Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation

  Blood · 2014 · https://doi.org/10.1182/blood-2013-12-543793

• Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester Disease

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2014.57.1950

• Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies

  Medicine · 2014 · https://doi.org/10.1097/md.0000000000000028

• High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

  Blood · 2012 · https://doi.org/10.1182/blood-2012-05-430140

• Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

  Blood · 2012 · https://doi.org/10.1182/blood-2012-07-446286

• CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients

  Blood · 2011 · https://doi.org/10.1182/blood-2010-06-294108

• Pathogenesis of Takayasu's arteritis: A 2011 update

  Autoimmunity Reviews · 2011 · https://doi.org/10.1016/j.autrev.2011.08.001

Current projects

No projects listed.